INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol INFINIUM
MSEI Symbol NOTLISTED
ISIN INE0MRE01011
Name of Company INFINIUM PHARMACHEM LIMITED
Type of company SME
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 28-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Single segment
Start date and time of board meeting 28-May-2025   11:45:00
End date and time of board meeting 28-May-2025   15:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion


Financial Results — Other than Bank
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 727281000 1557092000
Other income 10351000 21161000
Total Income 737632000 1578253000
2 Expenses
(a) Cost of materials consumed 534505000 1092887000
(b) Purchases of stock-in-trade 62386000 143329000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -70798000 -60180000
(d) Employee benefit expense 37065000 74293000
(e) Finance costs 20986000 36719000
(f) Depreciation and amortisation expense 17864000 32945000
(g) Other Expenses
1 other 84635000 142560000
Total other expenses 84635000 142560000
Total expenses 686643000 1462553000
3 Profit before exceptional and extraordinary items and tax 50989000 115700000
4 Exceptional items 0 0
5 Profit before extraordinary items and tax 50989000 115700000
6 Extraordinary items 0 0
7 Profit before tax 50989000 115700000
8 Tax Expense
Current tax 22440000 37039000
Deferred tax -1574000 230000
Total tax expenses 20866000 37269000
9 Net Profit Loss for the period from continuing operations 30123000 78431000
10 Profit (loss) from discontinuing operations before tax 0 0
11 Tax expense of discontinuing operations 0 0
12 Net profit (loss) from discontinuing operation after tax 0 0
13 Profit (loss) for period before minority interest 30123000 78431000
14 Share of profit (loss) of associates 0 0
15 Profit (loss) of minority interest 7274000 3022000
16 Net profit (Loss) for the period 37397000 81453000
17 Details of equity share capital
Paid-up equity share capital 155831000 155831000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 938812000
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 2.57 5.6
Diluted earnings (loss) per share from continuing and discontinued operations 2.57 5.6
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio
23 Disclosure of notes on financial results


Remarks
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 115700000
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 36719000
Adjustments for depreciation and amortisation expense 32945000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 4788000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss) 74452000
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories -195597000
Adjustments for decrease (increase) in trade receivables -132938000
Adjustments for decrease (increase) in other current assets -191243000
Adjustments for increase (decrease) in trade payables 78727000
Adjustments for increase (decrease) in other current liabilities -8857000
Adjustments for provisions 7796000
Total adjustments for working capital -442112000
Total adjustments for reconcile profit (loss) -367660000
Net cash flows from (used in) operations -251960000
Dividends received 0
Interest paid 0
Interest received -1035000
Income taxes paid (refund) 38582000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities before extraordinary items -291577000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) operating activities -291577000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 52534000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 33946000
Cash advances and loans made to other parties 1106000
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 1035000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -185513000
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items -272064000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) investing activities -272064000
Cash flows from used in financing activities
Proceeds from issuing shares 411032000
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 0
Dividends paid 0
Interest paid 36719000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 418606000
Net cash flows from (used in) financing activities before extraordinary items 792919000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) financing activities 792919000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 229278000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 229278000
Cash and cash equivalents cash flow statement at beginning of period 119122000
Cash and cash equivalents cash flow statement at end of period 348400000


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Equity and liabilities
1 Shareholders' funds
Share capital 155831000
Reserves and surplus 938812000
Money received against share warrants 0
Total shareholders' funds 1094643000
2 Share application money pending allotment 0
3 Deferred government grants 0
4 Minority interest 153331000
5 Non-current liabilities
Long-term borrowings 99968000
Deferred tax liabilities (net) 0
Foreign currency monetary item translation difference liability account 0
Other long-term liabilities 0
Long-term provisions 0
Total non-current liabilities 99968000
6 Current liabilities
Short-term borrowings 418494000
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 2304000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 121552000
Total Trade payable 123856000
Other current liabilities 75570000
Short-term provisions 17992000
Total current liabilities 635912000
Total equity and liabilities 1983854000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 207620000
Producing properties 0
Intangible assets 33945000
Preproducing properties 0
Property, Plant and Equipment capital work-in-progress 8472000
Intangible assets under development or work-in-progress 0
Total Property, Plant and Equipment and Intangible assets 250037000
ii Non-current investments 290248000
v Deferred tax assets (net) 1489000
vi Foreign currency monetary item translation difference asset account
vii Long-term loans and advances 4659000
viii Other non-current assets 38252000
Total non-current assets 584685000
Current assets
Current investments 0
Inventories 442542000
Trade receivables 337467000
Cash and cash equivalents 115013000
Bank balance other than cash and cash equivalents 233387000
Short-term loans and advances 80700000
Other current assets 190060000
Total current assets 1399169000
Total assets 1983854000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Ashok Rajpara & Co Yes 31-Dec-2026